Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Comera Life Sciences Q3 EPS $(0.10) Up From $(0.20) YoY, Sales $136.31K Down From $234.92K YoY

Author: Benzinga Newsdesk | November 09, 2023 09:18am
Comera Life Sciences (NASDAQ:CMRA) reported quarterly losses of $(0.10) per share. This is a 50 percent increase over losses of $(0.20) per share from the same period last year. The company reported $136.31 thousand in sales this quarter. This is a 41.98 percent decrease over sales of $234.92 thousand the same period last year.

Posted In: CMRA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist